Proliferative activity in human brain tumors: Comparison of histopathology and L-[1-11C]tyrosine PET

Journal of Nuclear Medicine

Volumn 38, Issue 9, 1997, Pages 1369-1374

  De Wolde, Heleen ^a   Pruim, Jan ^a   Mastik, Mirjam F ^a   Koudstaal, Jan ^a   Molenaar, Willemina M ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Brain tumors; L 1 11C TYR; PET; Proliferation; Protein synthesis rate

Indexed keywords

CARBON 11; KI 67 ANTIGEN; TYROSINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; BRAIN SCINTISCANNING; CANCER GROWTH; CELL PROLIFERATION; CHROMOSOME NOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; ISOTOPE LABELING; MALE; MENINGIOMA; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; STEREOTAXIC SURGERY;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CELL DIVISION; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEOLUS ORGANIZER REGION; SILVER STAINING; TOMOGRAPHY, EMISSION-COMPUTED; TYROSINE;

EID: 0030931816     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Coleman RE, Hoffman JM, Hanson MW, Sostman HD, Schold SC. Clinical application of PET for the evaluation of brain tumors. J Nucl Med 1991;32:616-622.
2. Byrne TN. Imaging of gliomas. Semin Oncol 1994;21:162-171.
3. Olivero WC, Dulebohn SC, Lister JR. The use of PET in evaluating patients with primary brain tumors: is it useful? J Neurol Neurosurg Psychiat 1995;57:250-252.
4. Di Chiro G, Brooks RA, Patronas NJ, et al. Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann Neurol 1984;15(suppl):S138-S146.
5. 18F]fluorodeoxyglucose positron emission tomography. Ann Neurol 1991;29:347-355.
6. 18F]fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1986;22:360-371.
7. Vaalburg W, Coenen HH, Crouzel C, et al. Amino acids for the measurement of protein synthesis in vivo by PET. Nucl Med Biol 1992;19:227-237.
8. Derlon JM, Bourdet C, Bustany P, et al. Carbon-11-L-methionine uptake in gliomas. Neurosurgery 1989;25:720-728.
9. Vaalburg W, Elsinga PH, Paans AMJ. Carbon-11 amino acids, labeling and metabolites. In: PET studies on amino acid metabolism and protein synthesis. Dordrecht: Kluwer Academic; 1993:75-80.
10. Paans AMJ, Vaalburg W, Woldring MG. A comparison of the sensitivity of PET and NMR for in vivo quantitative metabolic imaging. Eur J Nucl Med 1985;11:73-75.
11. Bolster JM, Vaalburg W, Paans AMJ, et al. Carbon-11-labeled tyrosine to study tumor metabolism by PET. Eur J Nucl Med 1986;12:321-324.
12. 14C]tyrosine for the investigation of a kinetic model to measure protein synthesis rates with PET. J Nucl Med 1988;29:524-529.
13. 11C]-tyrosine and PET. J Nucl Med 1995;36:411-419.
14. 11C]tyrosine PET for visualization and quantification of protein synthesis rate. Neuroradiology 1995;197:221-226.
15. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-1715.
16. Zuber P, Hamou MF, de Tribolet N. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. Neurosurgery 1988;22:364-368.
17. Raghavan R, Steart PV, Weller RO. Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study. Neuropathol Appl Neurobiol 1990;16:123-133.
18. Giangaspero F, Doglioni C, Rivano MT. Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol 1987;74:179-182.
19. Catoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-363.
20. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T. Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol 1994;87:47-54.
21. Bloom SE, Goodpasture C. An improved technique for selective silver staining of nucleolar organizer regions in human chromosomes. Hum Genet 1976;34:199-206.
22. Lindler LE. Improvements in the silver-staining technique for nucleolar organizer regions (AgNOR). J Histochem Cytochem 1993;41:439-445.
23. Shi SR. Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-748.
24. Emanuels A, Hollema H, Koudstaal J. Autoclave heating: an alternative method for microwaving? Eur J Morphol 1994;32:337-340.
25. Howell WM, Black DA. Controlled silverstaining of nucleolus organizer regions with a protective colloidal developer: a 1-step method. Experientia 1980;36:1014-1015.
26. Emmers R. The AgNOR staining: a quantitative and qualitative study [in Dutch]. Histotechniek 1990;9:109-115.
27. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumors. Brain Pathol 1993;3:255-268.
28. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumors of the central nervous system. Berlin; Springer Verlag: 1993.
29. Leek RD, Alison MR, Sarraf CE. Variations in the occurrence of silver-staining nucleolar organizer regions (AgNORs) in non-proliferating and proliferating tissues. J Pathol 1991;165:43-51.
30. Trerè D, Farabegoli F, Cancellieri A, Ceccarelli C, Eusebi V, Derenzini M. AgNOR area in interphase nuclei of human tumors correlates with the proliferative activity evaluated by bromodeoxyuridine labeling and Ki-67 immunostaining. J Pathol 1991;165:53-59.
31. Derenzini M, Pession A, Trerè D. Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab Invest 1990;63:137-140.
32. Korkolopoulou P, Christodoulou P, Papanikolaou A, Thomas-Tsagli E. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections. Am J Surg Pathol 1993;17:912-919.
33. Louis DN, Meehan SM, Ferrante RJ, Hedley-Whyte ET. Use of the silver nucleolar organizer region (AgNOR) technique in the differential diagnosis of central nervous system neoplasia. J Neuropathol Exp Neurol 1992;51:150-157.
34. Shiraishi T, Tabuchi K, Mineta T, Momozaki N, Takagi M. Nucleolar organizer regions in various human brain tumors. J Neurosurg 1991;74:979-984.
35. 18FDG in prolactinomas in relation to bromocryptine treatment. Eur J Nucl Med 1991;18:453-460.
36. 11C-L-methionine. J Neurooncol 1986;3:397-404.
37. Sato K, Kameyama M, Ishiwata K, Hatazawa J, Katekura R, Yoshimoto T. Dynamic study of methionine uptake in glioma using positron emission tomography. Eur J Nucl Med 1992;19:426-430.
38. 11C-labeled amino acids in Walker 256 carcinosarcoma-bearing rats. Nucl Med Biol 1990;18:197-204.
39. Ishiwata K, Kubota K, Murakami M, et al. Re-evaluation of amino acid PET studies: can the protein synthesis rate in brain and tumor tissues be measured in vivo? J Nucl Med 1993;34:1936-1943.
40. Delahunt B, Bethwaite PB, Nacey JN, Ribas JL. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumor grade, mitotic index and silver-staining nucleolar organizer region members. J Pathol 1993;170:471-477.
41. 11C-labeled ryrosine and dihydroxyphenylalanine. Eur J Nucl Med 1988;14:382-387.
42. Onda K, Davis RL, Wilson CB, Hoshino T. Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein and nucleolar organizer region counts in glioblastoma multiforme. Acta Neuropathol 1994;87:586-593.
43. Josza L, Kannus P, Jarvinen M, Isola J, Kvist M, Lehto M. Atrophy and regeneration of rat calf muscles cause reversible changes in the number of nucleolar organizer regions. Lab Invest 1993;69:231-237.
44. Ruschoff J, Elsasser HP, Adler G. Correlation of nucleolar organizer regions with secretory and regenerative process in experimental cerulein-induced pancreatitis in the rat. Pancreas 1995;11:154-159.
45. Takeda N, Diksic M, Yamamoto YL. The sequential changes in DNA synthesis, glucose utilization, protein synthesis and peripheral benzodiazepine receptor density in C6 brain tumors after chemotherapy to predict the response of tumors to chemotherapy. Cancer 1996;77:1167-1179.